Worldwide, over 170 million people have hepatitis C virus (HCV) infections. Chronic infection with HCV leads to liver diseases such as cirrhosis and hepatocarcinoma and is the major reason of liver transplantation. Currently, the standard treatment for hepatitis C relies on a combination of interferon-a and ribavirin (an immune booster and a general inhibitor of virus replication, respectively)...